hVIVO (HVO) is a specialty biopharma discovery and clinical testing company that is pioneering a human disease technology platform that models respiratory (airway) and infectious diseases. After raising £20m at 225p this could be the last year of losses…….
The Interims to June reported the strongest sales pipeline for several years and translation into active negotiations, with top-tier pharmaceutical companies, should lead to long term contracts. Based in the UK, more than 50 clinical studi...
You are unauthorized to view this page.
